In the Clinic: The New Ultralong-Acting Insulins

Volume 3, Issue 12.

In this podcast, Dr. Roma Gianchandani from the University of Michigan identifies scenarios in which patients can benefit from ultralong-acting insulins and discuss the potential negatives of ultralong-acting insulins.

Take our post-test to claim CME credits:
Physician post-test
Nurse post-test

To read a companion newsletter click here.

Clinical Implications of CGM in Patients with Type 2

Volume 3, Issue 10.

In this podcast, Dr. Roma Gianchandani from the University of Michigan identifies scenarios in which patients can benefit from ultralong-acting insulins and discuss the potential negatives of ultralong-acting insulins.

Take our post-test to claim CME credits:
Physician post-test
Nurse post-test

To read a companion newsletter click here.

Intensifying Glycemic Therapy with a Fixed Ratio Basal Insulin/GLP-1 RA Combination

Volume 3, Issue 8.

In this podcast Dr. Anders Carlson from the University of Minnesota Medical School discusses the clinical implications of continuous glucose monitoring (CGM) in patients with type 2 diabetes.

Take our post-test to claim CME credits:
Physician post-test
Nurse post-test

To read a companion newsletter click here.

Clinical Insights: Management of Type 2 Diabetes in Older Adults

Volume 3, Issue 6.

In this podcast Drs. Amisha Wallia and Susan Karam discuss clinical insights to managing elderly patients with T2DM.

Take our post-test to claim CME credits:
Physician post-test
Nurse post-test

To read a companion newsletter click here.

Cardiovascular Outcomes in Type 2 Diabetes Management

Volume 3, Issue 2.

In this podcast, Dr. Nestoras Mathioudakis from Johns Hopkins University School of Medicine discusses how the focus on cardiovascular outcomes can impact current clinical practice when managing patients with type 2 diabetes.

Take our post-test to claim CME credits:
Physician post-test
Nurse post-test

To read a companion newsletter click here.

Efficacy and Safety of MK-1293 Insulin Glargine Compared with Originator Insulin Glargine (Lantus) in Type 2 Diabetes (T2D)

Volume 2, Issue 13, Part 3.

Nestoras Mathioudakis, MD from Johns Hopkins interviews Dr. Marc Rendell from Creighton University School of Medicine about the study: Efficacy and Safety of MK-1293 Insulin Glargine Compared Along with Originator Insulin Glargine (Lantus) in Type 2 Diabetes, presented at the June 2016 American Diabetes Association Scientific Session.

A Patient-Centered Approach for Individualization of Pharmacotherapy in Obesity Care

Volume 2, Issue 13, Part 2.

Nestoras Mathioudakis, MD from Johns Hopkins interviews Dr. Jeffrey I. Mechanick from the Icahn School of Medicine at Mt. Sinai about his presentation: A Patient-Centered Approach for Individualization of Pharmacotherapy in Obesity Care, presented at the May 2016 AACE Annual Scientific and Clinical Congress.

Inpatient Glycemic Management: From the Bedside to the Cloud

Volume 2, Issue 13, Part 1.

Nestoras Mathioudakis, MD, MD from Johns Hopkins interviews Dr. Sethu Reddy from Cleveland Clinic about the seminar: Inpatient Glycemic Management: From Bedside to the Cloud presented at the May 2016 AACE Annual Scientific and Clinical Congress.